Ranbaxy launches de-stress drug in Japan

Pharma major Ranbaxy today said it has launched hypertension drug Amlodipine tablets in Japan.

The company launched its first independently developed generic drug Amlodipine tablets in 2.5 mg and 5 mg variants in Japan.

The drug is currently the largest molecule, which has gone off patent in Japan.

It has a market size of around two billion dollars (Rs 8.500 crore approx), the company said.

Earlier in April, the drug major had received approval from the Japanese Ministry of Health and Labour Welfare (MHLW).

The tablet the first product developed by any foreign generic pharmaceutical company outside Japan and subsequently being granted approval by MHLW (Japan).

Since 2004, Ranbaxy has filed seven products in Japan.

Source: http://www.mid-day.com/news/2008/jul/230708ranbaxy.htm